Regulation (EU) No 576/2013 of the European Parliament and of the CouncilDangos y teitl llawn

Regulation (EU) No 576/2013 of the European Parliament and of the Council of 12 June 2013 on the non-commercial movement of pet animals and repealing Regulation (EC) No 998/2003 (Text with EEA relevance)

ANNEX IU.K. Species of pet animals

PART AU.K.

Dogs (Canis lupus familiaris)

Cats (Felis silvestris catus)

Ferrets (Mustela putorius furo)

PART BU.K.

Invertebrates (except bees and bumble bees covered by Article 8 of Directive 92/65/EEC and molluscs and crustaceans referred to respectively in points (e)(ii) and (e)(iii) of Article 3(1) of Directive 2006/88/EC).

Ornamental aquatic animals as defined in point (k) of Article 3 of Directive 2006/88/EC and excluded from the scope of that Directive by point (a) of Article 2(1) thereof.

Amphibia

Reptiles

Birds: specimens of avian species other than those referred to in Article 2 of Directive 2009/158/EC.

Mammals: rodents and rabbits other than those intended for food production and defined under ‘lagomorphs’ in Annex I to Regulation (EC) No 853/2004.

ANNEX IIU.K. Technical requirements for transponders

The transponders must:

(a)

comply with ISO Standard 11784 and apply HDX or FDX-B technology; and

(b)

be capable of being read by a reading device compatible with ISO Standard 11785.

ANNEX IIIU.K. Validity requirements for anti-rabies vaccinations

1.The anti-rabies vaccine must:U.K.

(a)

be a vaccine other than a live modified vaccine and fall within one of the following categories:

(i)

an inactivated vaccine of at least one antigenic unit per dose (recommendation from the World Health Organisation); or

(ii)

a recombinant vaccine expressing the immunising glycoprotein of the rabies virus in a live virus vector;

(b)

where it is administered in a [F1member State or Northern Ireland], it must have been granted a marketing authorisation in accordance with:

(i)

Article 5 of Directive 2001/82/EC [F2, as it has effect in European Union Law, as amended from time to time]; or

(ii)

Article 3 of Regulation (EC) No 726/2004 [F3, as it has effect in European Union law, as amended from time to time];

(c)

where it is administered in [F4a third country which is not a member State], have been granted an approval or a licence by the competent authority and meet at least the requirements laid down in the relevant part of the Chapter concerning rabies in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organisation for Animal Health;

(d)

[F5where it is administered in Great Britain, have been granted a marketing authorisation in accordance with regulation 4 of the Veterinary Medicines Regulations 2013.]

Textual Amendments

2.An anti-rabies vaccination must fulfil the following conditions:U.K.

(a)

the vaccine was administered by an authorised veterinarian;

(b)

the pet animal was at least 12 weeks old at the date on which the vaccine was administered;

(c)

the date of administration of the vaccine is indicated by an authorised veterinarian or an official veterinarian in the appropriate section of the identification document;

(d)

the date of administration referred to in point (c) does not precede the date of application of the transponder or tattoo or the date of reading of the transponder or the tattoo indicated in the appropriate section of the identification document;

(e)

the period of validity of the vaccination starts from the establishment of protective immunity, which shall not be less than 21 days from the completion of the vaccination protocol required by the manufacturer for the primary vaccination, and continues until the end of the period of protective immunity, as prescribed in the technical specification of the marketing authorisation referred to in point 1(b) [F6or (d)] or the approval or licence referred to in point 1(c) for the anti-rabies vaccine in [F7Great Britain or the] third country where the vaccine is administered.

The period of validity of the vaccination is indicated by an authorised veterinarian or an official veterinarian in the appropriate section of the identification document;

(f)

a revaccination must be considered a primary vaccination if it was not carried out within the period of validity referred to in point (e) of the previous vaccination.

Textual Amendments

ANNEX IVU.K.Validity requirements for the rabies antibody titration test

1.The collection of the sample of blood necessary to carry out the rabies antibody titration test must be carried out and documented by an authorised veterinarian in the appropriate section of the identification document;U.K.

2.The rabies antibody titration test:U.K.

(a)

must be carried out on a sample collected at least 30 days after the date of vaccination and:

(i)

not less than three months before the date of:

  • the non-commercial movement from F8... a third country other than those listed in [F9Part 1 or 2 of Annex 2 to the Commission Implementing Regulation], or

  • the transit through such a F10... third country, where the conditions laid down in point (c) of Article 12 are not fulfilled, or

(ii)

before the pet animal left [F11Great Britain] for movement to or transit through F12... a third country other than those listed [F13in Part 1 or 2 of Annex 2 to the Commission Implementing Regulation]; the identification document in the format provided for in [F14Article 25(1)] must confirm that a rabies antibody titration test was carried out with a favourable result before the date of movement;

(b)

must measure a level of neutralising antibody to rabies virus in serum equal to or greater than 0,5 IU/ml and using a method prescribed in the relevant part of the Chapter concerning rabies in the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the World Organisation for Animal Health [F15, except where point 2A applies];

(c)

must be performed in a laboratory approved in accordance with Article 3 of Decision 2000/258/EC [F16or Article 3 of Decision 2000/258/EC as it has effect in European Union law, as amended from time to time];

(d)

does not have to be renewed following a satisfactory result described in point (b), provided that the pet animal is revaccinated within the period of validity referred to in point 2(e) of Annex III of the previous vaccination.

Textual Amendments

[F172A.

This point applies where the Secretary of State has administered a test which measures a level of antibody to rabies virus in serum of the animal tested equal to or greater than 0.3 EU/ml and using an enzyme linked immunosorbent assay method that meets the validation standards set out in Chapter 1.1.6. of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2022.]

[F18This point applies where, the Welsh Ministers have administered a test which measures a level of antibody to rabies virus in serum of the animal tested equal to or greater than 0.3 EU/ml and using an enzyme linked immunosorbent assay method that meets the validation standards set out in Chapter 1.1.6 of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2022;]

[F19This point applies where, before [F201 April 2023], the Scottish Ministers have administered a test which measures a level of antibody to rabies virus in serum equal to or greater than 0.3 EU/ml using an enzyme linked immunosorbent assay method that meets the validation standards set out in Chapter 1.1.6 of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2021 of the World Organisation for Animal Health.]

Textual Amendments

ANNEX VU.K.

Correlation table referred to in Article 43(2)

Regulation (EC) No 998/2003This Regulation
Article 1Article 1
First paragraph of Article 2Article 2(1)
Second paragraph of Article 2Point (a) of Article 2(2)
Third paragraph of Article 2Point (b) of Article 2(2)
Point (a) of Article 3Points (a) and (b) of Article 3
Point (b) of Article 3Point (f) of Article 3
Point (c) of Article 3Article 2(1)
First subparagraph of Article 4(1)
First subparagraph of Article 17(1)
Second subparagraph of Article 4(1)Second subparagraph of Article 17(1)
Article 4(2)—
Article 4(3)—
Article 4(4)—
Point (a) of Article 5(1)Point (a) of Article 6
Point (b) of Article 5(1)Point (d) of Article 6
Point (b)(i)Article 5(1)Point (b) of Article 6
Point (b)(ii) of Article 5(1)Point (c) of Article 6
Second subparagraph of Article 5(1)Article 19
Article 5(2)Article 7
Article 6—
Article 7Article 5(5), Articles 9, 14 and 28
Article 8(1)Articles 10 and 12
Article 8(2)Article 10(1)(e) and Article 27
Point (a) of Article 8(3)Article 13(1)
Point (b) of Article 8(3)Article 16
Point (c) of Article 8(3)Article 11
Article 8(4)Article 25(1) and (2)
Article 9Article 14 and Article 30(1) and (2)
First subparagraph of Article 10Article 13(2)
Second subparagraph of Article 10Article 13(3)
First sentence of Article 11Article 37(1)
Second sentence of Article 11Point (a) of Article 34(4)
Introductory phrase and point (a) of the first subparagraph of Article 12Article 10(2) and Article 34(1)
Introductory phrase and point (b) of the first subparagraph of Article 12Article 5(4)
Second subparagraph of Article 12Article 34(3) and Article 37(2)(d)
Article 13Article 34(3) and Article 37(2)(d)
First paragraph of Article 14Point (a) of Article 34(2)
Second paragraph of Article 14Second subparagraph of Article 17(1)
Third paragraph of Article 14Article 35(1) and (3)
Fourth paragraph of Article 14Article 35(2)
Article 15Points 1 and 2(c) of Annex IV
Article 16—
First paragraph of Article 17—
Second paragraph of Article 17Article 21(1)
First paragraph of Article 18—
Second paragraph of Article 18Article 36
Article 19Article 13(3) and Article 5(5)
Article 19a(1) and (2)Article 38
Article 19a(3)—
Article 19b(1)Article 39(2)
Article 19b(2)Article 39(4)
Article 19b(3)Article 39(1)
Article 19c(1) and (3)Article 39(3)
Article 19c(2)—
Article 19d(1) and Article 19d(2)Article 39(5)
Article 19d(3)—
Articles 20 to 23—
Article 24(1), (2) and (3)Article 41(1), (2) and (3)
Article 24(4) and (5)—
Article 25Article 45
Annex IAnnex I
Annex IaAnnex II
Annex IbAnnex III
Part A and Section 1 of Part B of Annex II—
Section 2 of Part B of Annex IIArticle 13(1)
Part C of Annex IIArticle 13(2)